Department of Molecular and Human Genetics, Institute of Science, Banaras Hindu University, Varanasi-221005, India,
Department of Molecular and Human Genetics, Institute of Science, Banaras Hindu University, Varanasi 221005, India.
Front Biosci (Landmark Ed). 2020 Mar 1;25(8):1568-1599. doi: 10.2741/4868.
Stem cells exist in many niches throughout the body and have the ability to self replicate and to differentiate to many lineages. As of a result of the advances in stem cell-based therapies, regenerative medicine is witnessing remarkable development. Encouraging positive outcomes from the use of stem cells in various diseases are extremely promising.. The popularity of stem cell-based therapy is due to its flexibility and potent approach in the treatment of numerous diseases. Treatment with genetically configured HSCs favors the engraftment of transplantation without rejection. MSCs hold an immunoregulatory capacity, elicit immunosuppressive effects and are immune-privileged cells, due to the low expression of MHCII and costimulatory molecules on their cell surface. Encouraging, positive outcomes from the use of stem cells in immunodeficiency, cancer, hemoglobinopathy, bone, cartilage repair, autoimmune disorders, cardiac and neuronal diseases are extremely promising. Successful stem cells based clinical trials are the game changers in the progress of clinical use of stem cells. This review provides an up to date comprehensive overview of the clinical efficacy of stem cells.
干细胞存在于体内的许多龛位中,具有自我复制和分化为多种谱系的能力。由于基于干细胞的治疗方法的进步,再生医学正在取得显著的发展。干细胞在各种疾病中的应用取得积极成果的前景非常广阔。基于干细胞的治疗之所以如此受欢迎,是因为它在治疗多种疾病方面具有灵活性和强大的方法。使用基因配置的造血干细胞进行治疗有利于移植而不发生排斥。间充质干细胞具有免疫调节能力,通过其细胞表面低表达 MHCII 和共刺激分子来引发免疫抑制作用,并成为免疫特惠细胞。干细胞在免疫缺陷、癌症、血红蛋白病、骨和软骨修复、自身免疫性疾病、心脏和神经疾病中的应用取得积极成果的前景非常广阔。成功的基于干细胞的临床试验是干细胞临床应用进展中的游戏规则改变者。这篇综述提供了干细胞临床疗效的最新全面概述。